Correlation Between Dennys Corp and Abcellera Biologics
Can any of the company-specific risk be diversified away by investing in both Dennys Corp and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dennys Corp and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dennys Corp and Abcellera Biologics, you can compare the effects of market volatilities on Dennys Corp and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dennys Corp with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dennys Corp and Abcellera Biologics.
Diversification Opportunities for Dennys Corp and Abcellera Biologics
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Dennys and Abcellera is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Dennys Corp and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and Dennys Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dennys Corp are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of Dennys Corp i.e., Dennys Corp and Abcellera Biologics go up and down completely randomly.
Pair Corralation between Dennys Corp and Abcellera Biologics
Given the investment horizon of 90 days Dennys Corp is expected to generate 5.47 times less return on investment than Abcellera Biologics. In addition to that, Dennys Corp is 1.02 times more volatile than Abcellera Biologics. It trades about 0.01 of its total potential returns per unit of risk. Abcellera Biologics is currently generating about 0.06 per unit of volatility. If you would invest 275.00 in Abcellera Biologics on September 13, 2024 and sell it today you would earn a total of 27.00 from holding Abcellera Biologics or generate 9.82% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Dennys Corp vs. Abcellera Biologics
Performance |
Timeline |
Dennys Corp |
Abcellera Biologics |
Dennys Corp and Abcellera Biologics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dennys Corp and Abcellera Biologics
The main advantage of trading using opposite Dennys Corp and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dennys Corp position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.The idea behind Dennys Corp and Abcellera Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Abcellera Biologics vs. Hepion Pharmaceuticals | Abcellera Biologics vs. Krystal Biotech | Abcellera Biologics vs. CureVac NV | Abcellera Biologics vs. Vir Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |